Rubicon Research Limited operates as a specialty pharmaceutical company in India, the United States, and internationally. Its primary proprietary technologies for drug delivery comprising RubiSRL for the formulation of sustained release liquids using a combination of ion exchange and membrane diffusion controlled-release technologies; and RubiReten, a gastro-retentive system for drugs with poor solubility and a limited window of absorption. The company develops products in the areas of analgesics/pain management, hypokalemia, gastrointestinal, cardiovascular, skeletal muscle relaxants, metabolic, central nervous system, nicotine replacement therapy, and immunosuppressant. The company was incorporated in 1999 and is based in Mumbai, India.
Low
570.75
High
1,899.00
Low
1,605.20
High
1,670.00
Company's profit divided by outstanding shares.
Ratio of share price to its earnings per share.
Total number of outstanding shares.
Gap between today's open and yesterday's close.
Average daily traded volume.
Highest price reached in the last 30 days.
Lowest price reached in the last 30 days.
Highest price reached in the last six months.
Lowest price reached in the last six months.
Highest price reached in the last year.
Lowest price reached in the last year.
How RUBICON RESEARCH LIMITED stacks up against its Drug Manufacturers - General peers on price, valuation and the 52-week range. Tap any column header to sort.
| # | Name | Price | Chg % | P/E | EPS | Mkt Cap (Cr) | 1M % | 1Y % | 52W H/L |
|---|---|---|---|---|---|---|---|---|---|
| 1 | RUBICON RUBICON RESEARCH LIMITED | 1,628.00 | 0.53% | 93.28 | 17.45 | 26,949 | 8.34% | 159.03% | 1,899.00 / 570.75 |
| 2 | CORONA CORONA REMEDIES LIMITED | 2,021.10 | 3.45% | 62.11 | 32.54 | 12,412 | 5.96% | 42.93% | 2,292.40 / 1,336.60 |
| 3 | GLAXO GlaxoSmithKline Pharmaceuticals Limited | 2,760.00 | 0.34% | 43.77 | 63.05 | 46,965 | 6.56% | 0.93% | 3,120.70 / 2,088.10 |
| 4 | MARKSANS Marksans Pharma Limited | 323.05 | 0.23% | 28.32 | 11.41 | 14,719 | 1.00% | 90.70% | 350.95 / 155.00 |
| 5 | NGLFINE NGL Fine-Chem Limited | 2,900.00 | 0.33% | 31.27 | 92.73 | 1,792 | 1.19% | 102.51% | 3,602.00 / 1,271.00 |
| 6 | PFIZER Pfizer Limited | 3,857.00 | 0.47% | 24.00 | 160.70 | 17,654 | 20.77% | 25.83% | 5,578.50 / 3,792.10 |
| 7 | SAIPARENT SAI PARENTERALS LIMITED | 522.80 | 1.23% | 106.53 | 4.91 | 2,310 | 0.43% | 28.40% | 706.00 / 400.00 |
| 8 | SANOFI Sanofi India Limited | 3,040.00 | 0.56% | 21.62 | 140.59 | 6,995 | 7.23% | 40.91% | 4,898.00 / 3,001.10 |
| 9 | SANOFICONR SANOFI CONS HEALTHC IND L | 3,775.20 | 0.73% | 32.68 | 115.51 | 8,722 | 10.15% | 26.46% | 5,255.00 / 3,691.00 |
| 10 | SENORES SENORES PHARMACEUTICALS L | 1,335.30 | 3.64% | 0.00 | 27.03 | 6,150 | 11.45% | 93.48% | 1,599.00 / 684.60 |
| 11 | SMSPHARMA SMS Pharmaceuticals Limited | 470.95 | 1.19% | 42.23 | 11.15 | 4,411 | 32.98% | 98.04% | 494.45 / 245.21 |
| 12 | TTKHLTCARE TTK Healthcare Limited | 1,012.20 | 1.06% | 19.34 | 52.34 | 1,431 | 7.52% | 14.00% | 1,247.00 / 735.00 |